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A B S T R A C T
Most of us have experienced deterioration of mood while ill. In humans, immune activation is associated with
lethargy and social withdrawal, irritability and aggression; changes in social motivation could, in theory, lead to
less functional interactions. This might also be the case for animals housed in close confinement. Tail biting in
pigs is an example of damaging social behavior, and sickness is thought to be a risk factor for tail biting out-
breaks. One possible mechanism whereby sickness may influence behavior is through cytokines. To identify
possible mediators between immune activation and behavioral change, we injected 16 gilts with lipopoly-
saccharide (LPS; O111:B4; 1.5 μg kg−1 IV through a permanent catheter). In LPS-treated pigs, a significant in-
crease in cortisol, TNF-α, IL-1 receptor antagonist, IL-6, and IL-8 was observed alongside decreased activity
within the first 6 h after the injection. CRP was elevated at 12 and 24 h after injection, and food intake was
reduced for the first 24 h after injection. Three days post-injection, LPS pigs had lower levels of noradrenaline in
their hypothalamus, hippocampus and frontal cortex compared to saline-injected pigs. Pigs injected with LPS
also had higher levels of the pro-inflammatory cytokine IFN-γ in their frontal cortex compared to saline-injected
pigs. Thus, a low dose of LPS can induce changes in brain cytokine levels and neurotransmitter levels that persist
after inflammatory and stress markers in the periphery have returned to baseline levels.
1. Introduction
Several studies suggest associations between health and tail biting
behavior in pigs [1–6]. A possible mechanism by which health could
influence behavior is through the effect of cytokines on hormone levels
and neurotransmitter systems. Cytokines are small proteins produced
by immune cells. Their effects can be both pro- and anti-inflammatory,
and they are part of the mechanisms that help the organism cope with
infectious and non-infectious challenges. Knowledge about the effects
of cytokines on behavior primarily comes from two areas: descriptions
of the behavioral consequences of naturally occurring illness—so-called
‘sickness behavior’ in mammals [7, 8]—and observations of the side
effects experienced by human patients subject to immune therapy, e.g.
for hepatitis or metastatic cancer [9, 10]. Sickness behavior is mainly
elicited by the pro-inflammatory cytokines interleukin 1β (IL-1β), tu-
mour necrosis factor α (TNF-α) and interleukin 6 (IL-6) and manifests
as anorexia, lethargy and decreased social motivation [7]. However,
lethargy and social withdrawal are not the only behavioral changes
brought about by cytokine increase. Depression, irritability and short
temper, anger/hostility, extreme emotional lability, tearfulness and
cognitive impairment have been reported in clinical studies on the ef-
fects of treatment with pro-inflammatory cytokines such as IL-2 and
interferon alpha [9–12]. There also are indications that inflammatory
proteins may play a role in aggression, as elevated levels of IL-6 and C-
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reactive protein (CRP) have been found in psychiatric patients with a
diagnosis of intermittent explosive disorder [13]. However, in many of
these reports, which came first—the cytokine response or the beha-
vior—cannot be ascertained.
If cytokines do play a role in the aetiology of tail biting, it must be
by increasing the likelihood that a pig will become either a victim or a
biter. Our hypothesis is that if a pig is ill to such an extent that it shows
social withdrawal, lethargy or signs of depression, it could be singled
out as a victim since it would differ from the rest of the group. Sick
animals may be preferred as competitors, as victory is more certain if
one competes with a sick conspecific than with a healthy one [14]. On
the other hand, irritability, emotional lability and short temper in a pig
housed in close confinement could lead to biting behavior.
Findings in rodents and humans indicate that two possible me-
chanisms by which cytokines may exert their effects on behavior are by
altering monoaminergic signalling [15, 16] or by stimulating gluta-
matergic signalling [17]. Interestingly, monoaminergic signalling seems
to differ between biters, victims and neutral pigs. Both biters and vic-
tims have been found to have increased serotonin turnover compared to
neutral pigs [18]. Ursinus et al. [19] showed a lower level of serotonin
storage in blood platelets in biters and victims, which could indicate an
increased use of tryptophan for the formation of central serotonin.
Dopamine turnover was increased in the victims [18].
The study of causal relationships between health and behavior in
pigs held under commercial conditions is difficult because of a lack of
both control and standardisation. Experimental models of immune sti-
mulation are easier to work with, as the strength, type and timing of
immune stimulation can be controlled. Bringing animals into an ex-
perimental facility also provides the opportunity to perform detailed
observations that may be difficult to perform in the field. The results
from model experiments can therefore be more easily used to identify
possible mechanisms underlying the phenomenon of interest, and to
guide later field studies. The injection of lipopolysaccharide (LPS), a
component of the cell wall of gram-negative bacteria, is one relatively
well-characterised model treatment that leads to immune activation.
LPS binds CD14 and Toll-like receptor 4 and leads to the activation of
transcription factors such as NF-κB. The activation of these transcrip-
tion factors increases the production of pro-inflammatory cytokines,
stimulates the production of acute phase proteins in the liver, and ac-
tivates the HPA-axis [20–26]. Pigs injected with LPS at moderate doses
show decreased activity, exploration and eating behavior [27], and an
increased latency to approach a human in the home pen [28]. With
higher doses, lethargy may be more pronounced and longer-lasting
[29]. However, pigs are rarely studied for longer than 12 h, precluding
the possibility of detecting long-lasting effects on behavior and phy-
siology. Most experiments on pigs focus on LPS-induced changes in
TNF-α, IL-6 and sometimes IL-1β [30–33]. However, other cytokines
may also be influenced by LPS injection and could contribute to
changes in physiology and behavior. To identify candidate mechanisms
linking immune activation with behavior, detailed information about
the time-course of changes in the levels of more than the three ‘clas-
sical’ pro-inflammatory cytokines (TNF-α, IL-6 and IL-1β), as well as
CRP, cortisol, monoaminergic neurotransmitters and behavior is ne-
cessary.
We therefore injected pigs with a low dose of LPS and measured
changes in time budgets and food intake over three days post-injection.
We measured the time-course of changes in 13 different cytokines, and
characterised effects on leukocytes, cortisol, CRP and skin temperature.
At euthanasia, 72 h post-injection, brain samples were collected for
monoamine and cytokine analysis.
2. Materials and methods
2.1. Experimental design and ethical permit
This experiment was approved by the national animal research
authority (FOTS id 7002). An overview of the experimental design is
provided in Fig. 1. Pigs were kept in the experimental unit for four
weeks before the surgical fitting of a permanent central venous catheter
into one jugular vein. During this time, they were habituated to the
environment and handlers. LPS was injected five to six days after sur-
gery. Relative to the time of injection, blood samples and temperature
measurements were taken 30min before LPS injection (referred to as 0,
or baseline) and at 1, 2, 3, 4, 6, 8, 12, 24 and 72 h post-injection. Video-
recordings of behavior in the home pen ran continuously throughout
the study. Food was weighed in the morning every 24 h. Hay was
provided in the afternoon of every day. At euthanasia, brains were re-
moved and samples dissected and snap-frozen in isopentane on dry ice
within 10min. The hippocampus, frontal cortex and hypothalamus
were analysed for monoamines (dopamine, serotonin and noradrena-
line and their metabolites) and 13 different cytokines.
Fig. 1. An overview of the experimental design. The timing of samples, tests and other registrations are shown on the timeline from three days before LPS injection to
three days after LPS injection.
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2.2. Animals and husbandry
Sixteen female pigs (Landrace Yorkshire x Duroc Duroc) were used
for this study. As gender may influence the immune response [34], we
decided against including both gilts and barrows as it would have ne-
cessitated a larger sample size. Female pigs were chosen as they are not
castrated. Castration is a surgical procedure and thus has the potential
to induce an immune response, potentially influencing the response to
later LPS treatment [35].
Eight pigs were allocated to the LPS treatment (LPS), and eight pigs
were allocated to the control treatment (saline injection: SAL). All pigs
were transported from their farm to the experimental facility on the day
of weaning, i.e. at approximately five weeks of age. According to the
farmers, the pigs had no previous history of illness and had not been
treated with antibiotics before arrival at the experimental unit. The pigs
for the two replicates came from two different commercial farms within
one hour's driving distance from the experimental facility. The eight
pigs per replicate consisted of four sibling pairs. In each sibling pair,
one pig was allocated to the LPS group and the other to the control
(SAL) group. The allocation was done in a balanced way within the
room so that there was an equal number of LPS and control pigs close to
and farther away from the entrance. Each sister pair could see and hear
one another through the pen division, and they could also have limited
tactile contact through the fence dividing the pens. The pigs were fed ad
libitum with a piglet diet (‘Ideal Junior’, Norgesfôr, Oslo, Norway), and
had free access to drinking water. The pens (115 cm×163 cm) had
solid concrete flooring with a rubber mat covering part of the area, and
wood shavings and hay were added after the pens were cleaned every
day. The lights were on from 8:00 am to 4:00 pm every day, and the
room was also partly lit by daylight from windows. In addition, lights
were turned on after 4:00 pm, during sampling. The temperature varied
from 18 to 22 °C. The catheters (see below for a description of the
surgical protocol) were flushed with heparinized saline after sampling,
and in addition four times per day: 09:00, 12:00, 15:30 and 21:00.
2.3. Surgical procedure and anaesthetic protocol
A complete overview of all substances and doses is provided in
Table 1. All pigs were premedicated in their home pen with a mixture
containing ketamine, midazolam, and medetomidine injected in-
tramuscularly with a standard hypodermic needle attached to a syringe
with extension tubing. Next, a catheter was placed in the auricular vein.
Propofol was administered to effect in order to allow orotracheal in-
tubation, and anaesthesia was maintained with isoflurane mixed with
100% oxygen. All pigs were mechanically ventilated to maintain nor-
mocapnia. Ampicillin was administered to prevent infection of the
surgical wound. Buprenorphine and flunixin were administered in-
travenously to provide postoperative analgesia, and Ringer-acetate was
administered at 5ml/kg/h throughout the procedure. A heating mat-
tress was used to prevent hypothermia. Pigs were monitored by a
trained veterinary anaesthetist (AL and JR) until they had fully re-
covered.
An experienced surgeon was responsible for central venous cathe-
terisation in all 16 pigs. After aseptic preparation of the incision site,
the pig was placed in dorsal recumbency. An incision was made ven-
trally in the midline of the neck, from the rostral end of the sternum and
cranially towards an imaginary line running between the angles of the
mandible. A combination of sharp and blunt dissection was used to
reach the internal jugular vein. The vein was ligated by placing a su-
ture. Caudal to that suture, a rubber tube was used to stabilise the vein
for cannulation. Before cannulation, a custom-made steel cannula was
used to make a subcutaneous tunnel from the incision side up to the
dorsal aspect of the neck, where the sharp end was used to perforate the
skin. The catheter (Ernæringssonde 31,010,181, length 1000mm,
2.7 mm outer diameter, OneMed, Oslo, Norway), was pulled through
the steel cannula, and the cannula was removed so that the catheter
remained in the tunnel. With the catheter ready to be inserted into the
vein, the vein was elevated by pulling on the suture and the rubber
tube. A pair of scissors was used to make a small incision in the vein,
with one blade inserted into the incision to keep the gap open as the
catheter was inserted. The catheter was eased approximately 5 cm into
the vein in the caudal direction and secured by a suture encompassing
the vein and catheter. The incision was closed with two subcutaneous
sutures and one skin suture. Bandages and a custom-made backpack
protected the catheter and ensured easy access.
For the first two days following the surgery, the pigs received flu-
nixin for pain management and ampicillin to prevent infection (see
Table 2 for a complete overview of all substances used in this experi-
ment).
2.4. LPS injection
The study was run in two blocks of eight pigs each. Within each
block, pigs were injected with LPS five or six days after surgery. Two
sister pairs were injected on the same day, including two saline- and
two LPS-treated pigs. The remaining two sister pairs within each block
were injected on the following day. The reason for injecting only half of
the pigs on each day was to allow sampling within a short period, thus
minimising disturbance to the animals. All pigs were injected between
09:20 and 10:10 in the morning. The average weight on the day before
injection was 25.9 ± 3.5 kg.
Before the injection day, the lyophilised LPS (from Escherichia coli
Table 1
Overview of substances used, with dose and route of administration indicated.
Active substance Generic name and concentration of active substance Dose per kg bw and route of
administration
Procedure
Ketamine Ketalar (100mgml−1) 6mg kg−1 IM Premedication
Tiletamin Zoletil forte vet 2.845mg kg−1 IV Anaesthesia prior to euthanasia
Zolazepam 2.845mg kg−1 IV Anaesthesia prior to euthanasia
Midazolam Midazolam (5mgml−1) 1mg kg−1 IM Premedication
Medetomidine Domitor vet (1 mgml−1) 0.04mg kg−1 IM Premedication
0.057mg kg−1 IV Anaesthesia prior to euthanasia
Buprenorphine Vetergesic vet (0.3mgml−1) 0.02mg kg−1 IM Premedication
Butorphanol Butomidor (10mgml−1) 0.181mg kg−1 IV Anaesthesia prior to euthanasia
Ampicilline Pentrexyl (powder dissolved in 0.9% NaCl) 40mg kg−1 IV Administered just before surgery as prophylaxis;
continued the first two days post-surgery
Propofol Propovet (10mgml−1) to effect As needed for endotracheal intubation
Isoflurane to effect Gas-anaesthesia during surgery
Ringer-acetate 5ml kg−1 h−1 Fluid administration during surgery
Flunixin meglumine Finadyne vet (50mgml−1) 2.2mg kg−1 IV Post-operative pain management (how many days)
LPS Serotype 0111:B4 of Escherichia coli (Sigma) dissolved in
0.9% sterile saline to a concentration of 20 μgml−1
1.5 μg kg−1 IV Activation of the immune system
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0111:B4 (Sigma-Aldrich, Darmstadt, Germany)) was dissolved in sterile
0.9% saline to a concentration of 2mgml−1 and frozen in glass vials.
On the injection day, a vial was thawed, and the LPS solution was
further diluted in sterile 0.9% saline to a final concentration of
20 μgml−1. Each pig was weighed before injection. The LPS solution
was injected into the catheter using a Hamilton glass syringe. The LPS
dosage was 1.5 μl kg−1. Immediately after injection, the catheter was
flushed with 10ml of sterile saline to ensure that all of the LPS reached
the circulation.
2.5. Recording and scoring of home pen behavior
Twenty-four-hour video recordings were performed to test how the
LPS injection would influence the home pen behavior of the pigs. An
infrared camera was positioned above the centre of the pen and record-
ings were made using the Media Recorder system from Noldus
(Wageningen, the Netherlands). Daytime behavior was scored by scan-
sampling with 10-min intervals for 2 5-h segments of time per day ac-
cording to the ethogram in Table 2. If a person was in the room at the
time of a scan, the video was rewound 2min; if the person was already in
the pen at that time, the scan was excluded from analysis. Two hours were
omitted between the segments due to husbandry and sampling. The first
scan was sampled 10min after the injection of LPS. The time was equal
within sister pairs and kept the same for all days of observation.
Synchronisation of activity within sister pairs was defined as a scan
where both sisters were either active (i.e. behavior category ACTIVE in
Table 3) or inactive (i.e. behavior category SLEEP or ALE-INA in
Table 3). Synchronisation was assessed for each scan throughout the
observation of time budgets.
Behavior was scored over four days altogether, including one day
before LPS injection, the day of injection, and two days post-injection.
2.6. Blood sampling
Blood was sampled by syringe through the catheter with minimal
stress to the pigs (Fig. 1). After sampling, the catheter was always flu-
shed with 5- to 10-ml of sterile 0.9% saline. The blood was transferred
to EDTA tubes for cytokine analysis and flow cytometry, and to ad-
ditive-free tubes for CRP analysis. The EDTA tubes for cytokine analysis
were centrifuged for 10min at 1000×g and plasma was transported on
ice to a −80 °C freezer. The blood for CRP analysis and flow cytometry
was brought directly to the lab for analysis upon sampling. Sample
volume was kept to a minimum: 1–2ml for cytokine analysis, 1 ml for
haematology, 3ml for flow cytometry and 1ml for CRP measurement.
2.7. Sampling of brain tissue
On the day of euthanasia, the pigs were injected intravenously
Table 2
Ethogram for scoring of time budgets.
Behavior category Behavior Definition
Alert but inactive (ALE-INA) Lying alert Lying down with head up
Sitting alert Dog-sitting with head up
Standing alert Standing with head up
Performing active behavior (ACTIVE) Moving Walking, running or jumping with head up
Exploration Snout touching bedding, enrichment material or pen fixtures except for the inside of the feeder or drinker
Social behavior Attempt to touch another pig with the snout through the fence, with both pigs touching the fence
Feeding Snout in feeder
Drinking Snout in waterer
Elimination Defecating or standing in crouched position
Comfort behavior Rubbing body against pen fixtures or rolling on the ground
Lying inactive (SLEEP) Lying inactive Head resting against the ground and not moving, body (parts) may make sharp, sudden, short-lasting movements
Table 3
Results from the mixed model analysis (or non-parametric between-group comparisons) for all 12 cytokines. The result for the treatment by time interaction is shown,
as are the post hoc between-group comparisons. The Bonferroni-corrected critical p-value is 0.004. Details concerning transformations and alternatives to the mixed
model are shown in the rightmost column. All analyses were run on fluorescence intensity data, as detailed in materials and methods section.
Cytokine Time by treatment interaction Post hoc testing for between-group comparisons (12 comparisons, critical
p-value= .004)
Statistical method or transformation
IFN-γ NS
IL-1α Significant, but no relevant post hoc results
for between-group comparisons
IL-1β Significant, but no relevant post hoc results
for between-group comparisons
IL-1ra F10, 110= 62.26; p < .0001 Significantly higher levels in the LPS group at 2, 3, 4, 6, 8, 12 and 24 h
(p < .0001 for all comparisons); Tendency to a difference at 1 (p= .0048) and





IL-6 Significant, but could not be transformed to
give satisfying homogeneity of variance
Significantly higher levels in the LPS group at 1, 2 and 3 h (p=.0034 for all) Wilcoxon test comparing LPS and
SAL at each time point
IL-8 F10, 110= 27.44; p < .0001 Significantly higher levels in the LPS group at 2 and 3 after injection
(p < .0001 for both)
Mixed model, Box-cox
transformation
IL-10 Significant, but could not be transformed to
give satisfying homogeneity of variance
No differences Wilcoxon test comparing LPS and
SAL at each time point
IL-12 Significant, but no relevant post hoc results
for between-group comparisons
IL-18 Significant, but could not be transformed to
give satisfying homogeneity of variance
No differences Wilcoxon test comparing LPS and
SAL at each time point
TNF-α F10, 110= 50.89; p < .0001 Significantly higher levels in the LPS group at 1, 2 (p < .0001) and 3
(p < .0007) h after injection
Mixed model, Box-cox
transformation
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through their catheters with a mixture of tiletamine (2.845mgkg−1),
zolazepam (2.845mgkg−1), butorphanol (0.181mgkg−1) and medeto-
midine (0.057mgkg−1). This injection was administered in the home
pen, and the pigs lost consciousness within seconds after the injection.
After transport to the dissection room, they were euthanised by an in-
jection of pentobarbital into the catheter. The skull was opened using a
bone saw and chisel, and the brain was removed. Samples from the fol-
lowing parts were immediately dissected and frozen in isopentane on dry
ice: the hippocampus (left and right), the hypothalamus (left and right)
and the frontal cortex (left and right). Following freezing, the samples
were stored at −80 °C until analysis. The frontal cortex was sampled by
placing a transverse section approximately 2 cm caudal to the apex of the
frontal lobe. The hippocampus was obtained by blunt dissection after
having cut through the corpus callosum to separate the left and the right
hemisphere down to the level of the thalamus. The hypothalamus was
collected by using the optic chiasm and the corpus mammilare (included
in the sample) as reference points. Underlying tissue was included by
placing two section lines at 45° to the imaginary line between the optic
chiasm and the corpus mammilare so that in essence, the tissue block
resembled a triangle. The frontal cortex was sampled due to the im-
portance of this area for the control of behavior, the regulation of mood,
and the perception of external stimuli [36–40]. The hippocampus was
included based on its role in cognition and memory [41–43] and the
hypothalamus was collected due to its importance in the regulation of the
stress response, appetite and fever [44–46].
2.8. Multiplex cytokine analysis in blood and brain tissue
Cytokines were measured in plasma and brain tissue by a multiplex
assay including the cytokines GM-CSF, IFN-γ, IL-1α, IL-1ra, IL-1β, IL-2, IL-
4, IL-6, IL-8, IL-10, IL-12, IL-18 and TNF-α (PCYTMAG 23K, (Merck,
Darmstadt, Germany)). The detection limits can be found in the supple-
mentary materials (Table S1). The treatment of brain tissue before ana-
lysis is described below. Plasma samples or brain homogenate were
thawed and centrifuged at 4 °C at 1000×g for 10min, and the super-
natant was transferred to new Eppendorf tubes. A mixture of antibody-
coupled microspheres was incubated with standards, samples, quality
controls or blanks (wells receiving buffer only) in a total of 75 μl.
Incubation on a plate shaker at 2–6 °C overnight was followed by a wash
step and 2 h of incubation with biotinylated detection antibodies at room
temperature. The microspheres were then washed again and incubated
with 0.1 μg PE-labeled streptavidin for 30min. Following an additional
wash and resuspension in sheath fluid, the microspheres were analysed on
the Luminex100 (Bio-Rad, Hercules, CA) using the BioPlex Manager 6.0
software (Bio-Rad, Hercules, CA). All assays were incubated in darkness.
Tissue blocks were cut from the frontal cortex, hippocampus and
hypothalamus samples. Each block was weighed (frontal cortex: average
weight ± sd: 87.7 ± 39.0mg; hippocampus: 74.4 ± 26.1mg; hy-
pothalamus: 38.3 ± 21.4mg). Two blocks per sample (except for the
hypothalamus, which could only be cut into two blocks in total) were
analysed for monoamines (see paragraph below), and one block per
sample was analysed for cytokines (as described here). The tissue was
homogenised using a modified published procedure [47]. Tissue blocks
were weighed and placed in 2-ml round bottomed Eppendorf tubes, each
containing 0.5ml of cell lysis buffer (from The Cell Lysis Kit
(#171–304,012), Bio-Rad; see Table 1). The solution contained a protease
inhibitor cocktail (#171–304,012, Bio-Rad) and one μl of a stock solution
containing 500mM phenylmethylsulfonyl fluoride (#P-7626) in dimethyl
sulphoxide (#D2650, both from Sigma, St. Louis, MO). Each tube also
contained a 5-mm tungsten bead. Samples were mechanically homo-
genised at room temperature for 4min using a TissueLyser II (Cat.No
85300, Qiagen) set at 20Hz. The homogenate was centrifuged at 4400 x g
for 15min at 4 °C (Heraeus Multifuge 3SR+ Centrifuge, Thermo Fisher
Scientific, MA, USA). We then collected 200 μL supernatant from each
tube and stored it at −80 °C until the bead array analysis of cytokine
content described above.
2.9. Cortisol analysis
Cortisol was measured in plasma using an enzyme immunoassay kit
(DetectX®, Catalog number K003-HW5, Arbor Assays, MI, USA). The kit
reagents were prepared according to the kit protocol.
Plasma samples were thawed and centrifuged at 4 °C at 1000×g for
10min. After the dissociation reagent (DR) had been allowed to warm
to room temperature, five μl of DR were transferred to Eppendorf tu-
bes—one tube per sample—and 5 μl of plasma supernatant were added
to the DR in each tube. The mixture was diluted by adding 490 μl of
assay buffer (1:1000 dilution), then vortexed and incubated at room
temperature for at least 5 min. All samples were used within 2 h of
preparation.
All standards, quality controls and samples were run in duplicates.
Fifty microliters of samples, quality control high/low or standards,
were pipetted in appropriate wells. Each well then received 25 μl of
DetectX® cortisol conjugate, followed by 25 μl of DetectX® cortisol an-
tibody using a repeater pipet. After incubation on a shaker at room
temperature for 1 h, the plate was aspirated, and each well was washed
four times with 300 μl of wash buffer. Then, 100 μl of TMB substrate
was added to each well, and the plate was incubated for 30min at room
temperature. Fifty microliters of stop solution were added before the
optical density generated from each well was read.
2.10. C-reactive protein analysis
Sentrallaboratoriet at NMBU's Faculty of Veterinary Medicine
(www.sentrallaboratoriet.no) uses a polyethylene glycol (PEG) en-
hanced immunoturbidimetric assay to measure CRP in serum on an
Advia®1800 Chemistry System (Siemens AG, Erlangen, Germany). The
sample is reacted with specific antiserum to form a precipitate that is
measured turbidimetrically at 340 nm [48].
2.11. Haematology and flow-cytometry
Blood samples were collected in EDTA-containing tubes.
Haematological differential counts were retrieved in an Advia® 2120
Haematology System (Siemens AG, Erlangen, Germany). Peripheral
blood mononuclear cells (PBMCs) were isolated at each time point by
density gradient centrifugation (2210×g, 30 min) on Lymphoprep™
(Axis-Shield, Dundee, Scotland) and immediately cryopreserved using
Recovery™ cell culture freezing medium (Gibco, Thermo Fisher
Scientific) for further storage in liquid nitrogen. On the day of flow
cytometric analysis, cells from all comparable time points were thawed.
The cells were first stained using a LIVE/DEAD® Fixable Yellow dead
cell stain kit (Life Technologies/Invitrogen, Oslo, Norway), following
the manufacturer's instructions (Table S6 in the supplementary mate-
rials provides an overview of the antibodies and secondary reagents
used for flow cytometric immunophenotyping in this study). Next, the
cells were suspended in a buffer containing 10% porcine plasma, and
incubated with monoclonal antibodies and subsequent secondary re-
agents. For intracellular antigens, the cells were permeabilised and
fixed using an Intracellular Fixation & Permeabilization Buffer Set
(Affymetrix/eBioscience, Thermo Fisher Scientific). Flow cytometry
was performed with a 3-laser Gallios flow cytometer (Beckman Coulter,
CA, USA), and gating was based on staining with secondary antibodies
only or isotype controls. Data were analysed using Kaluza software
(Beckman Coulter, CA, USA). Absolute lymphocyte counts were calcu-
lated from haematological analyses as follows: The absolute count of
peripheral blood mononuclear cells (PBMC), calculated as lymphocyte
+ monocyte counts, was multiplied with the relative percentage of
each cell subset obtained from flow cytometry and divided by 100,
resulting in absolute cell subset counts ∗10^9/l.
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2.12. Analysis for monoamines in brain tissue
The brain samples were treated in accordance with [18], with some
modifications. They were cut from frozen blocks of tissue, weighed
(frontal cortex: average weight ± sd: 49.7 ± 20.7 mg; hippocampus:
53.6 ± 18.5 mg; hypothalamus: 32.2 ± 9.7mg) and homogenised in
0.5 ml of homogenisation solution consisting of six-parts 0.2MHCLO4
and one-part antioxidant solution containing oxalic acid in combination
with acetic acid and L-cysteine. The homogenates were centrifuged at
20,800×g for 35min at 48 °C. The supernatant was removed to 0.5 ml
Vivaspin filter concentrators (10,000MWCO PES, Sartorius, Stone-
house, UK) and centrifuged at 8600g at 4 °C for 35min. Filtrates con-
taining monoamines were analysed using high-pressure liquid chro-
matography with electrochemical detection. The analytes were
separated on a Phenomenex Kinetex 2.6 μm, 4.6× 100mm C-18
column (Phenomenex, Torrance, CA). The column was maintained at
45 °C with a column heater (Croco-Cil, Bordeaux, France). The mobile
phase consisted of 0.1 M NaH2 PO4 buffer, 120mg l−1 of octane sul-
fonic acid, methanol (5%), and 450mg l−1 of EDTA; the pH of the
mobile phase was set to 3 using H3PO4. The pump (ESA Model 582
Solvent Delivery Module; ESA, Chelmsford, MA) was equipped with two
pulse dampers (SSI LP-21, Scientific Systems, State College, PA) and
provided a flow rate of 1mlmin−1. One hundred microliters of the
filtrate were injected into the chromatographic system with a Shimadzu
SIL-20 AC autoinjector (Shimadzu, Kyoto, Japan). Monoamines and
their metabolites were detected using an ESA CoulArray Electrode
Array Detector with 12 channels. The chromatograms were processed
and concentrations of monoamines calculated using ESA's CoulArray for
Windows® software. Analyses of dopamine (DA) and its main metabo-
lites 3,4-dihydroxyphenylacetic acid (DOPAC) and homovanillic acid
(HVA), noradrenaline (NA) and its main metabolite 3-methoxy-4-hy-
droxyphenylglycol (MOPEG), and serotonin (5-HT) and its main me-
tabolite 5-hydroxyindoleacetic acid (5-HIAA) were performed.
2.13. Surface temperature and food intake
To avoid stressing the pigs, we measured temperature on the skin
surface using an infrared thermometer (Fluke 574 cf., SR Automation
AS, Asker, Norway). The same person always measured temperatures,
taking care to keep a constant distance between the thermometer and
the skin surface (approximately 40 cm). The temperature was always
measured on a shaved area of the back, just behind the dressing that
secured the catheter. Food uptake was measured by weighing the feeder
with food each morning, and calculating the change in weight over the
preceding 24 h.
2.14. Data processing and statistical analysis
2.14.1. General description of data processing and statistical analysis
Due to occlusion problems with the catheters, the final group size
consisted of 7 pigs in the LPS group and 6 in the SAL group. Analyses of
continuous variables except for behavior were run in JMP Pro12 (SAS,
NC, USA). All variables were measured several times for each individual
and were analysed with mixed models, as detailed below. For variables
with a time repeat (all behavioral variables and all substances measured
in blood), pig nested in treatment is included as the random effect, and
time, treatment and their interaction as fixed effects. For variables with
a spatial repeat (brain monoamines and cytokines, as there was one
measurement per hemisphere and pig), pig nested in treatment is in-
cluded as a random effect, and hemisphere, treatment and their inter-
action are fixed effects. Analyses were run for each brain area sepa-
rately, as a difference between brain areas was not of interest. Also,
neurotransmitter values were in general 10 times higher in the hy-
pothalamus than the frontal cortex and hippocampus, so a joint analysis
of all brain areas in one model was not suitable.
For variables with repeats over time, the primary question was
whether there was a significant time by treatment interaction, as nei-
ther a main effect of time nor treatment was interesting in itself. Thus,
only the interaction is reported in detail in the Results section, and only
if the post hoc test yielded relevant results, i.e. differences between
treatment groups at the same time points. For variables with a spatial
repeat (brain monoamines and cytokines), the main effects of treatment
and hemisphere and their interaction were of interest, and results for
these are reported. All post hoc tests were done using the t-test with
Bonferroni correction. The critical p-value for post hoc tests, including
LPS–SAL comparisons, for all 12 time points (this is relevant for blood
cytokines and cortisol) is 0.004 (i.e. 0.05 divided by 12). The critical p-
value for post hoc tests including five comparisons (CRP, food intake) is
0.01. For variables not described separately below, their analysis fol-
lowed the description in this paragraph without exception. Results are
presented as mean ± sd or median (range).
2.14.2. Statistical analysis of behavioral data
The SPSS statistical package (version 22.0) was used for analysis of
behavioral variables. Behavioral variables were considered on the
hourly level, as activity was expected to have a certain rhythm over the
day and the effects of LPS were expected to last only a few hours.
Time budgets were analysed only on the level of the behavioral ca-
tegories given in Table 2, as the number of observations was low for most
behaviors. Behavioral category variables were expressed as the sum of
scans within each category for each hour. Synchronisation of activity was
expressed as the percentage of synchronised scans for each hour.
Time budgets and synchronisation of activity were analysed for the
effect of day within treatment and time budgets, and also for the effect
of treatment within day. For analysis of day effects, the data were split
into LPS and CTR for separate analysis in both treatment groups.
Behavioral variables for the injection days and the two days following
were compared pair-wise to pre-injection values using the Wilcoxon
Signed-Rank Test (hereafter Wilcoxon), considering day within in-
dividual as the repeated effect. For analysis of treatment effects, CTR
was compared to LPS using the Wilcoxon test, considering sister pair
within day as the repeated effect.
The non parametric Spearman correlation between the pro-in-
flammatory cytokines IL-1β, IL-6, IL-8 and TNF-α and number of scans
in which the pigs were lying inactive were tested separately for each
treatment at baseline and 1, 2, 3, 4 and 6 h after injection.
2.14.3. Statistical analysis of cytokine data
For all thirteen cytokines, a proportion of the analysed samples were
below the lower limit of detection (LOD), and the calculated cytokine
levels were consequently censored by the analysis software. Dealing
with censored data is a common problem in automated biological
measurements; a lack of consensus on how to deal with this has resulted
in many different analytical approaches, as discussed by Antweiler
(2015) and Breen et al. (2016) [49, 50]. Antweiler [49] concludes that
a comparison of instrument-generated values that include values below
LOD performs well—provided that no>40% of the measurements
have been censored on the basis of LOD—and recommends non-para-
metric statistical analysis. Breen et al. [50] discuss Luminex analysis
specifically, and conclude by recommending a similar approach. In the
present study, we excluded analytes from the statistical analysis
where>40% of measurements were censored. A table showing the
percentage of censored values for each cytokine can be found in the
supplementary material (Table S2). We then used all measured fluor-
escence intensity (FI) values without subtracting blank and ran a mixed
model (as described in the previous paragraph) if the data fulfilled the
requirements or could be transformed to do so. Average cytokine values
and standard deviations in ng ml−1 were obtained from the con-
centration values provided by the Bioplex manager software, to facil-
itate comparison with existing studies. It is important to note that these
are slightly overestimated compared to the FI values, as the LOD values
could not be included.
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2.14.4. Biological vs statistical significance
The cytokines and flow cytometry results are presented here with
statistical tests and p-values. However, the results indicate that some of
the variables that were not statistically different between groups
nevertheless had an important biological effect in the LPS pigs only. We
think this is the case for IL-12 and NK cells, and maybe also for IL-18.
The rationale for and implications of this claim will be presented in the
discussion, and tables providing an overview of the median cytokine
concentration in plasma (min-max) can be found in the supplementary
material (Tables S3 and S4).
3. Results
3.1. Measures of immune activation: C-reactive protein and cytokines in
blood
C-reactive protein was elevated after LPS injection both at 12 (LPS
mean (sd): 34.1 mg l−1 (7.9) SAL: 15.3 mg l−1 (4.7), p < .0001) and
24 h (LPS: 27.1 mg l−1 (2.5), SAL: 16.3 mg l−1 (6.1), p < .0007) (F 4,
43.02= 31.85; p < .0001), but not at 48 or 72 h. The two groups did
not differ at baseline (LPS: 24.2 mg l−1 (3.2), SAL: (19.2mg l−1 (6.6)).
For several cytokines, there was marked baseline variation, as well
as considerable variation over time for both SAL and LPS pigs. Three
cytokines differed from this pattern: IL-1ra, IL-8 and TNF-α had very
low baselines, little spread and a distinct peak for the LPS group, and
hardly any deviations from baseline within the SAL group. IL-1ra
peaked either at 3 or 4 h after injection. IL-8 peaked at 2 h post-injec-
tion, and TNF-α peaked at 1 h. Also, though it had considerably more
unexplained variation, IL-6 showed significant between-group differ-
ences at 1, 2 and 3 h after injection, peaking at 2 h. No other cytokines
differed significantly between groups. The results for IL1-β, IL-6, IL-8
and TNF-α in blood and IFN-γ in brain tissue are shown in Fig. 2, and
median values (range) for all cytokines can be found in Tables S2 and
S3 in the supplementary material. The results from the statistical ana-
lysis of the effect of treatment and time on cytokine levels can be found
in Table 3.
3.2. Brain cytokines
An overview of percent censored values in brain tissue, and the
number of censored samples from each group, can be found in the
supplementary material (Table S5). As screening of the raw data re-
vealed differences between brain areas regarding the level of cytokines,
censoring was calculated per brain area, and cytokines that were cen-
sored<40% in one brain area were analysed for that area even though
the overall level of censoring was above 40%. As a result, GM-CSF, IFN-
γ, IL-1α, IL-2, IL-8 and IL-18 were analysed for all brain areas, while IL-
1β was analysed for the hypothalamus only, IL-1ra was analysed for the
hippocampus only, and IL-4, IL-6, IL-10, IL-12 and TNF-α were not
analysed at all.
There were no treatment or hemisphere effects on the levels of IL-1β
in the hypothalamus or IL-1ra in the hippocampus. In the frontal cortex,
LPS pigs had higher levels of IFN-γ than SAL pigs (F (treatment) 1,
11.19= 7.27; p= .02). In the hippocampus, there was a tendency to-
wards a higher level of IL-18 in the right hemisphere of LPS pigs than in
the right hemisphere of SAL pigs (F(treatment ∗ hemisphere)
1,11= 3.83; p= .076. P= .1 for the post hoc Tukey comparison be-
tween the right hemispheres of the two groups). There were no other
significant differences between treatment groups or hemispheres.
3.3. Brain monoamines
The concentration of monoamines for each brain area is shown in
Table 4.
Noradrenaline (NA) levels were considerably lower in all three brain
areas of LPS pigs compared to SAL pigs (frontal cortex: F(treatment) 1,
11= 22.98, p < .0006; hippocampus: F(treatment) 1, 11= 5.31,
p < .042; hypothalamus F(treatment) 1, 11= 4.32, p < .062; see
Fig. 2). In the frontal cortex, NA turnover (measured as the ratio of
MOPEG to NA) was also affected (F(treatment)1,11= 5.6; p= .037) and
was lower in LPS than in SAL brains. In the hippocampus, the lower NA
level in LPS pigs was only found in a comparison between the left
hemispheres (p < .01), as the right hemispheres did not differ between
the two treatments (F(hemisphere ∗ treatment)1,11= 4.05; p= .07).
Furthermore, NA turnover in the hippocampus was not different be-
tween treatments, but there was an asymmetry in the MOPEG/NA ratio
between the left (lowest turnover) and right hemisphere in LPS pigs
(highest turnover, p < .008) that could not be detected in SAL pigs (F
(hemisphere ∗ treat) 1,11= 7.32; p= .021). In the hypothalamus, NA
turnover was not affected.
Dopamine did not seem to be affected by the LPS treatment, as no
differences between treatments were found for dopamine or dopamine
turnover (calculated as (DOPAC+HVA)/DA).
In the hippocampus, there was a tendency towards higher levels of
serotonin in the right hemisphere of LPS pigs compared to the right
hemisphere of SAL pigs (post hoc t-test, p= .015). We made four re-
levant comparisons: between each hemisphere and treatment and be-
tween hemispheres within treatment (the Bonferroni-corrected critical
p-value is 0.0125). The difference between hemispheres for the LPS pigs
was significant (p= .004) (F(treatment ∗ hemisphere)1, 11= 9.63;
p= .01, analysis on box-cox transformed data). The hippocampal 5-
HIAA/5-HT ratio showed trends in the same direction as the 5-HT re-
sults: p= .031 for the comparisons between hemispheres in the LPS
groups, and p= .095 for the comparison between right hemispheres for
SAL and LPS pigs (F(treatment ∗ hemisphere)1, 11= 4.19; p= .065).
Serotonin and serotonin turnover in the frontal cortex and hypotha-
lamus were not affected by treatment.
3.4. Cortisol
Cortisol increased after injection and was significantly higher in the
LPS than in the SAL group at 1, 2, 3 and 4 h (p < .0001 for all time
points; F(time ∗ treatment)10, 110= 14.05; p < .0001; analysis was
done on box-cox transformed values). The timing of the peak varied
between pigs and was at 2, 3 or 4 h after injection. The cortisol increase
was seen in all LPS pigs and no SAL pigs (Fig. 2A).
3.5. Haematology and flow-cytometry
In haematological analysis, absolute numbers of peripheral blood
mononuclear cells (PBMCs) increased following LPS injection, sig-
nificant at both 48 (p=0,0011, Bonferroni-corrected critical p-value is
0,0125) and 72 h (p=0,0008, Bonferroni-corrected critical p-value as
above) post-injection (F(time ∗ treatment)3, 32= 5,09; p= .0054)
(Fig. 2C). Total monocytes, neutrophils, eosinophils and basophils dis-
played no significant changes after injection. Cellular subsets were
measured in multi-colour flow cytometric immunophenotyping. To
detect which leukocyte subset contributed to this fluctuation, we cal-
culated the absolute cellular subset numbers by combining haema-
tology and immunophenotyping data as stated in the materials and
methods section. In this manner, we found that B-cells (CD21+/CD3−)
constituted the most prominently responding lymphocyte subset, sig-
nificantly elevated at 48 h (p=0,0067, Bonferroni-corrected critical p-
value as above) (Fig. 2C) (F(time ∗ treatment)3, 31= 3,64; p= .023). T-
cells (CD3+/CD21−) did not account for a significant rise (Fig. 2C).
Natural killer (NK) cells (CD3−/CD8+/NKp46−, CD3−/CD8+/
NKp46+ and CD3−/CD8−/NKp46+ [51] tended to be higher in LPS
pigs at 72 h (p=0,027, Bonferroni-corrected critical p-value as above)
(F(time ∗ treatment)3, 31= 14,9; p < .00001). The expression of the
surface activation markers CD25 and CD44 were measured on each
subset of NK cells, but there was no measurable increase detected in
either case (not shown). Similarly, intracellular perforin content was
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not significantly changed in total NK cells or any of the subsets at the
measured time points following LPS injection (not shown). Monocytes
were analysed on the level of two previously defined subsets:
CD14bright/CD163-and CD14dim/CD163+ (Fairbairn et al. [61]). The
former monocyte subset showed an early drop, significant at 24 h
(p=0,009, Bonferroni-corrected critical p-value as above), and then
stabilised at the initial level (F(time ∗ treatment)3, 31= 7,6; p= .0006)
(Fig. 2C). In contrast, CD14dim/CD163+ monocytes increased at a later
time point, significantly at 72 h post-injection (p=0,002, Bonferroni-
corrected critical p-value as above; (F(time ∗ treatment)3, 31= 9,7;
p < .0001)).
3.6. Food intake
The LPS group significantly decreased their food intake compared to
the SAL group during the first 24 h after injection (F 3,33= 4,03;
p= .01; post hoc t-test with a p(critical) of 0.0125: p < .0001; LPS:
average ± sd intake of 0.8 ± 0.4 kg/pig/24 h; Saline: average intake
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of 1.4 ± 0.4 kg/pig/24 h). However, the food intake of the LPS group
during the first 24 h after injection was not significantly lower than
baseline (p= .05 for the comparison with the baseline for the LPS
group: 1.1 ± 0.2 kg/pig/24 h). The SAL pigs tended to increase their
food intake in the first 24 h after injection (p= .02 for the comparison
with the SAL baseline). At 48 and 72 h, the food intake of the two
groups did not differ (from 24 to 48 h: LPS: average ± sd intake of
1.3 ± 0.3 kg/pig/24 h; Saline: 1.4 ± 0.1 kg/pig/24 h. From 48 to
72 h: LPS: average ± sd intake of 1.2 ± 0.3 kg/pig/24 h; Saline:
average intake of 1.2 ± 0.2 kg/pig/24 h.)
3.7. Temperature
Skin temperature was not influenced by the LPS injection. However,
surface recording of temperature, as attempted here, is not very reli-
able. Therefore, these results should be interpreted with caution.
3.8. Time budgets
The animals spent most of their time lying inactive. Active behavior,
mostly in the form of exploration, was primarily seen in the later hours
of the first 5-h observation slot.
The injection of LPS caused differences within sister pairs during
hours 2 and 3 (between-group comparisons: p < .1 at hour 2 and
p < .05 at hour 3), when LPS pigs were less active and slept more
compared to SAL pigs. Changes appeared to diminish during hour 4
(Fig. 3).
Changes in time budgets compared to pre-injection levels were
evaluated separately in SAL and LPS pigs. Significant differences were
present in SAL pigs at only a few distinct hours, whereas LPS pigs
showed decreases in ACTIVE and increases in SLEEP in hours 2–5 post-
injection (Fig. 3). For ALE-INA (alert but inactive), a few significant
results were seen for both treatments, but no pattern could be re-
cognised (data not shown).
3.9. Synchronisation of activity
The activity of the animals appeared to be fairly synchronised, as
judged by the general level of 4.5–5.5 synchronised scans out of
6 scans/h over most of the experimental days (Fig. 4). Synchronisation
appeared to be on a slightly higher level in the afternoon hours com-
pared to the hours before noon. The level of synchronisation did not
change significantly when compared to the pre-injection level during
the experiment, although a clear numerical decrease was evident 2–3 h
post-injection.
3.10. Correlations between selected physiological and behavioral variables
Inactivity in the LPS pigs (measured as number of scans in which the
pigs were scored as lying inactive) showed a significant and positive
correlation with TNF-α at 2 (Spearman's rho 0.92; p= .004) and 3 h
(Spearman's rho 0.87; p= .01) after LPS injection. Within the saline
group, there was no positive correlations, but a negative relationship
between IL-8 (Spearman's rho−0.9; p= .04) and IL-1β (spearman's rho
−1.0; p= .0001) and lying inactive at 4 h after injection.
4. Discussion
To our knowledge, this is the first experiment measuring 13 cyto-
kines in blood and cytokine and monoamine levels in brain tissue after
LPS injection in pigs. Our findings confirm and expand results from
previous research on the effect of LPS on pig behavior and physiology
[52]. The classical pro-inflammatory cytokines TNF-α and IL-6 peaked
at hours 1 and 2 post-injection, respectively. IL-1ra showed the stron-
gest response to LPS, which lasted for almost 48 h. IL-8 (also called
chemokine CXCL8) peaked at hour 2. Cytokines IFN-γ, IL-1α and -β, IL-
2, IL-4, IL-6, IL-10, IL-12 and IL-18 were not significantly affected but
were present in measurable quantities in> 60% of the samples. How-
ever, as mentioned in the materials and methods section, though they
did not reach statistical significance, some of these cytokines may still
have exerted a biologically important effect in the LPS pigs (discussed
further below). Cortisol was higher in LPS pigs from 1 to 4 h after in-
jection. CRP was not measured as frequently as cytokines and cortisol
but was increased at 12 and 24 h post-injection. Food intake dropped
during the first 24 h, and the pigs showed the commonly reported le-
thargy that disappeared by 6 h post-injection. This relatively short
duration of overt sickness is similar to that reported in several studies
on the effect of low doses of LPS in healthy human subjects [53–55].
Skin temperature was not influenced by the injection. Seventy-two
hours after injection, all behavioral signs of sickness were gone, and
blood values were back within the pre-injection range. However, brain
noradrenaline levels in LPS pigs were considerably lower in all three
brain areas investigated (hippocampus, hypothalamus and frontal
cortex). We only had enough measurable values to allow analysis for
GM-CSF, IFN-γ, IL-1α, IL-2, IL-8 and IL-18, but not for IL-1ra, IL-4, IL-6,
IL-10, IL-12 and TNF-α. IFN-γ, a cytokine that did not seem to be in-
fluenced by LPS when measured in blood, was found in higher levels in
the frontal cortex of LPS-treated pigs than in saline-treated pigs. It
should be noted that the limited sample size in this experiment—chosen
due to cost, practical considerations and the severity of the treat-
ment—would not allow us to detect small differences between the
treatment groups. For the main pro-inflammatory cytokines, the sample
size used in this and many other studies of LPS effects is sufficient be-
cause the effects of LPS are so strong, but more subtle changes would go
undetected. As the main figures and tables in the supplementary ma-
terials show, several of the cytokines had considerable baseline varia-
tion. This could be caused by a reaction to the catheter as shown in
calves for IL-6 [35]. Data on the same 13 cytokines collected from
clinically healthy uncastrated boars indicate lower variation [56].
However, there could also be an effect of age and gender and differ-
ences in housing conditions, so the validity of direct comparison with
the previous study is therefore questionable.
Fig. 2. Outlier box plots of selected behavioral and physiological variables plotted against time (0–72 h relative to injection) for LPS- (left panel) and SAL (right
panel) pigs. Significant differences between the LPS and saline group are marked with an asterisk over the saline group. Outliers are marked as black dots. Units of
measurements are given in the figure caption. A. Lying inactive, IL-1ra and cortisol levels and IL-1β, IL-6, IL-8 and TNFα levels in LPS (left panel) and SAL (right
panel) pigs at baseline (0) and up to 72 h after LPS injection. The concentrations of serum cytokines and cortisol are given as ng ml−1. The behavior is given as
number of scans with the indicated behavior. Significant differences between the LPS and saline group are marked with an asterisk over the saline group. In the case
of longer-lasting differences between the groups, a line marks all the time points at which the post-hoc comparison between the groups was significant. For p-values
and test statistics, see the Results section. B. Frontal cortex IFN-γ (ng mg−1) and noradrenaline (ng g−1), NK cells (absolute counts (×10^9/l)) and IL12 (ngml−1) (in
blood or serum respectively) plotted against time for LPS- (left panel) and SAL (right panel) pigs at baseline (0) and up to 72 h after LPS injection. Significant
differences between the LPS and saline group are marked with an asterisk over the saline group. In the case of longer-lasting differences between the groups, a line
marks all the time points at which the post-hoc comparison between the groups were significant. For p-values and test statistics, see the Results section. C. Absolute
counts (×10^9/l) of T cells, B cells, classical monocytes, intermediary monocytes, and peripheral blood mononuclear cells plotted against time for LPS- (left panel)
and SAL (right panel) pigs. See materials and methods section for the calculation of absolute counts. Significant differences between the LPS and saline group are
marked with an asterisk over the saline group. In the case of longer-lasting differences between the groups, a line marks all the time points at which the post-hoc
comparison between the groups was significant. For p-values and test statistics, see the Results section.
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Our results for the three main pro-inflammatory cytokines inter-
leukin 1β (IL-1β), tumour necrosis factor α (TNF-α) and interleukin 6
(IL-6) largely confirm the findings of earlier experiments [30, 33, 52].
We did not see a significant increase in IL-1β, but that was most likely
due to excessive baseline variation. The shape of the curve was quite
similar to that found by others, with a slow increase and a lack of a
distinct peak. When comparing effects of LPS in pigs between studies,
the dose and route of administration must be taken into account, as well
as the serotype of E. coli that the LPS was extracted from, as LPS ex-
tracted from different serotypes of E. coli differ in potency. We used LPS
from E. coli O111:B4. This serotype is commonly used in LPS experi-
ments in pigs, and all papers we compare our results to also used
O111:B4 unless otherwise mentioned. Historically, high doses of LPS
were used, e.g. 25 μg kg−1 [30, 33] and 75 μg kg−1 [57] (in these three
studies, LPS was administered intravenously), and 150 μg kg−1 IP [58].
However, de Groot et al. (2007) [59] reported that 4 μg kg−1 induced
vomiting, which they deemed unacceptable, and 1 μg kg−1 gave a
variable response. Two μg kg−1 induced a clear cortisol increase and
behavioral response [28]. Based on this and on results from a pilot
experiment, we chose our dose of 1.5 μg kg−1. The absolute con-
centrations of TNF-α and IL-6 are considerably higher in the studies
using 25 μg kg−1 or more than in our results, whereas IL-1β seems to be
less affected by dose [33, 57, 58]. Our results are therefore in line with
those of de Groot et al. [59]: A dose below 4 μg kg−1 is sufficient to
produce a reliable response.
Aside from TNF-α and IL-6, only IL-8 and IL-1ra increased sig-
nificantly in the LPS pigs compared to the control animals. For both IL-8
and IL-1ra, the peak was detected at 2 h post-injection, and the baseline
variation was low, with negligible levels before injection and
throughout the experiment for SAL pigs. IL-8, also called chemokine
CXCL8, is particularly important in aiding migration of neutrophils to
extracellular cites. IL-1ra is an anti-inflammatory cytokine that must be
present in considerably higher concentrations than IL-1β to exert its
effect. Thus, all pigs seemed to have a well-functioning anti-in-
flammatory response in the form of IL-1ra and cortisol. Cortisol in-
creased from an average baseline of 27 ngml−1 to a peak of
106 ngml−1 at 3 h post-injection. This peak is lower than the con-
centrations reported in previous studies in which the doses of LPS were
Fig. 2. (continued)
Table 4
Monoamine concentrations (ng g−1) in the frontal cortex, hippocampus and hypothalamus of LPS and SAL pigs 72 h after LPS injection. Hemisphere values are shown
only for noradrenaline and serotonin in the hippocampus. Between-group differences (LPS vs SAL) at p < critical value are marked in red. Within-group differences
(hemispheric differences within treatment) at p < critical value are marked in blue.
Brain area Treatment
LPS Saline
Noradrenaline Dopamine Serotonin Noradrenaline Dopamine Serotonin
Frontal cortex 124.1 (30.8) 9.5 (4.3) 82.1 (14.8) 204.2 (52.7) 11.9 (8.9) 69.0 (26.0)
Hippocampus 147.6 (71.3) 6.2 (2.9) 64.7 (45.5) 216.8 (43.3) 6.2 (2.8) 52.3 (30.6)
Left: 123.6 (55) Left: 35.9 (7.6) Left: 221.3 (48) Left: 57.8 (34.2)
Right: 171.6 (82) Right: 93.6 (50) Right: 212.4 (42) Right: 46.8 (28.6)
Hypothalamus 1708.0 (816.2) 159.3 (50.9) 284.1 (131.9) 2714.2 (497.4) 193.6 (49.1) 297.1(132.0)
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higher [30, 31, 33, 57]. The baseline value is considerably lower than
baselines reported from sampling by manual restraint and jugular
puncture, and similar to the baseline reported when using automated
sampling from in-dwelling catheters [60], highlighting how much
sampling technique can influence physiological measurements in pigs.
Monocytes in pigs can be divided into subsets grossly similar to
humans, whereby CD14bright/CD163− monocytes resemble ‘classical’
human monocytes and CD14dim/CD163+ resemble ‘intermediate’,
possibly also incorporating ‘non-classical’ monocytes [61]. The drop in
CD14bright/CD163- monocytes observed here 24 h post-injection is in
keeping with a human endotoxemia model. In this model, CD14+
monocytes dropped at 24 h [62], possibly due to rapid mobilisation of
such cells into lymphoid tissue, inflamed tissue, or both, as observed in
cows [63]. The later increase in CD14dim/CD163+ monocytes could be
due to replenishment from bone marrow, as well as maturation from
classical monocytes [64]. In humans, corresponding cells were found to
be an important LPS-responding source of several of the cytokines up-
regulated in our experiment, including TNFα, IL-8 and IL-6 [65]. Due to
their relatively long lifespan of 4–7 days in the human circulation [64],
these monocytes are likely mediators of cytokine production several
days beyond the initial acute phase. However, in the present study, the
cellular cytokine sources were not specifically addressed. Finally,
monocytes should be considered as direct mediators of
neuroimmunology; these cells can cross the blood-brain barrier in dis-
eased individuals, where they may develop into microglia and exert a
range of neurological effects [66]. Taken together, circulating mono-
cytes respond phenotypically to an LPS challenge, highlighting them as
candidate cells for further investigation.
We observed an increase in IFN-γ in the frontal cortex 72 h post-
injection. An early source of IFN-γ is NK cells, which were numer-
ically—though not significantly—increased in the circulation at 48 and
72 h compared to control pigs. During an endotoxin response, myeloid
cells produce cytokines such as IL-12 and IL-18, which activate NK cells
to produce large amounts of IFN-γ [67]. In the present study, LPS did
not increase plasma IL-12, IL-18 or IFN-γ significantly. However, the
endotoxin dosage given was low, and though circulating levels may be
highly diluted, local effects of monocytes and NK cells in the brain
could lie behind the IFN-γ increase in the frontal cortex. In mice in-
jected with LPS, microglia were found to be a likely source of locally
produced pro-inflammatory cytokines for several months after injection
[68]. IFN-γ is, in fact, the only cytokine that has been measured in
plasma after LPS injection in pigs, in addition to the three classical pro-
inflammatory cytokines IL-1β, IL-6 and TNF-α [58]. LPS is a potent
activator of the innate immune response, and in experiments that are
terminated within 12 h, only effects on the innate immune system can
be studied. It is nevertheless possible that LPS can induce adaptive
immunity either through the antigenic activity of the O-antigen or
possibly through induction of autoimmunity [67, 69–71]. Together
with the significant elevation in B-cells (CD21+/CD3−) at 48 h, the
numerical increase in NK cells and T cells may indicate the beginning of
an adaptive immune response in the LPS-injected pigs.
Changes in behavior coincided with the most pronounced physio-
logical effects of the injection, and at 2 and 3 h after the injection, in-
activity correlated significantly with TNF-α concentration in plasma in
the LPS but not the saline group. Daytime behavioral analyses indicated
that LPS induced marked passiveness in the injected pigs from hours
2–5 post-injection, in accordance with previous experiments in pigs
[27, 71–73]. The SAL sister appeared to respond to the changed be-
havior in her LPS-treated sibling by an initial increase in activity in
hours 2–3 post-injection, compared to baseline. This was followed by a
distinct decrease in activity in hours 4–5, corresponding to levels of
activity recorded in the LPS-treated sister. SAL pigs appeared to have
synchronised their activity with the LPS-treated pigs after a period of
increased activity, which may have been restlessness in response to
unexpected behavior by the control-treated sister. These observations
were evident in the analysis of synchronisation of activity also, with a
non-significant decrease in hours 2–3 followed by a return to baseline
levels from hour 4 post-injection. However, it cannot be ruled out that
Fig. 3. The average number of scans (± 2 SE) in
active behaviors on BASE day (left) and the day of
LPS injection (INJ, right). The dashed line represents
SAL and the uninterrupted line LPS pigs. Hours are
given in relation to the time of LPS injection.
Treatment effects (LPS vs SAL) are denoted with *
(p < .05) and † (p < .1) and day effects (BASE as
compared to INJ within treatment) with a (p < .05)
for LPS and b (p < .05) for SAL.
Fig. 4. Within-pair synchronisation of activity on the baseline (dashed line) and
LPS injection day (uninterrupted line). Error bars represent± SD.
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the passivity of SAL pigs simply shows that they were tired after a
period of high activity. Observations were not conducted in hours 6–7
post-injection, but from this time point, the behavior of both groups
appeared to be close to normal levels. It is possible that there was a
rebound in the form of slightly increased activity, compared to baseline
in both groups. No behavioral effects of LPS were evident in the second
or third day post-injection. Importantly, the pigs were housed singly so
as to avoid problems with the catheters. Thus, the social behaviors they
could display were limited and tail biting could not occur. The effect of
immune stimulation on social behaviour with more direct relations to
tail biting is the focus of a follow-up paper (Munsterhjelm et al., in
preparation). The aim of this paper was to detect immune-related
candidate mechanisms that could lead to behavioral changes associated
with tail biting. The increase in IFN- γ and the decrease in noradrenalin
may both influence social behavior, and will be the focus of future
experiments. They are discussed in more detail below.
Three days after LPS injection, when behavior and blood values
were back within the baseline range, noradrenaline levels were lower in
LPS pigs in all brain areas in which noradrenaline was measured, while
the level of IFN-γ was higher in the frontal cortex of LPS-treated pigs
than in the frontal cortex of saline-treated pigs. IFN-γ induces in-
doleamine 2,3-deoxygenase (IDO), which metabolises tryptophan to
kynurenine [74–76]. The increase in metabolism of tryptophan to ky-
nurenine rather than serotonin can have at least two consequences:
there might not be enough tryptophan to produce adequate amounts of
serotonin, there may be an increase in metabolites that can potentiate
glutamatergic signalling through the NMDA receptor, or both may
occur. Serotonin levels tended to be higher in the right hippocampus in
LPS-treated pigs compared to SAL pigs, and turnover was not affected
by the treatment, indicating that serotonergic signalling was not de-
creased due to immune stimulation. A similar finding was reported in
mice, in which whole brain serotonin turnover was increased 28 h after
LPS injection [75]. LPS injected pigs have been found to have an in-
crease in plasma kynurenine to tryptophan ratio [77], but the study was
terminated after less than 7 h after injection, so longer term effects
could not be measured. As we measured neither kynurenine levels nor
IDO activity, we cannot draw conclusions as to the importance of the
observed increase in frontal cortex IFN-γ.
The pigs injected with LPS had markedly lower noradrenaline levels
in their hypothalamus, left hippocampus and frontal cortex. Dopamine,
which is synthesised along the same pathway as noradrenaline, was not
affected. This selective effect of immune activation on noradrenaline
levels while leaving dopamine levels unchanged corresponds well with
earlier findings in rodents [78, 79]. Rats injected with an antigen or
with cytokine-containing extracts showed a marked reduction in their
hypothalamic noradrenaline content, and no change in dopamine levels
[78]. LPS is known to stimulate noradrenergic neurons in locus coerulus
(LC) within the first 30min after injection, with a corresponding in-
crease in noradrenaline levels [80, 81]. Intracerebroventricular ad-
ministration of IL-1β and IL-6 also stimulate noradrenergic neurons
[82]. This initial activation of noradrenergic pathways leads to a nor-
adrenaline increase in the hypothalamus, which is important for the
fever response normally observed after an LPS injection [83, 84]. It is
possible that a negative feedback mechanism after this initial nora-
drenergic activation explains the reduced levels three days after im-
mune stimulation. The reduced levels of noradrenaline we observed in
the pigs may be important for their cognitive function, their emotional
function, or both, as noradrenaline has a role in the regulation of mood
and cortical function. Reduced levels of noradrenaline have been pos-
tulated as one of the processes underlying depression, as many anti-
depressants increase noradrenaline availability. However, the compar-
ison between clinical observations in depressed human patients and
animal models is complicated by the fact that while antidepressants
may have an immediate effect on noradrenaline levels and on behavior
in some animal models, they take considerably longer to have a ther-
apeutic effect in human [85, 86]. This makes the inference that low
noradrenaline levels cause depression questionable. However, when
improvement is measured as a gradual return of some (but not all)
functions, the therapeutic lag is shorter and improved mood and re-
duced motor retardation may be seen within two weeks after initiating
treatment with a selective noradrenaline reuptake inhibitor [87]. This
supports the hypothesis that noradrenaline is important in the regula-
tion of mood. Noradrenaline also aids in focusing on salient, meaningful
stimuli [88], and is important for effortful attention [39]. How the ef-
fect of noradrenaline depletion in controlled tests of attention and
working memory translates to the effects on social behaviour in pigs
needs to be tested separately.
5. Conclusion
At 72 h post-injection, after the well-documented immediate
changes in physiology brought about by LPS injection have subsided,
our data suggest that brain noradrenaline levels are markedly reduced
in the hippocampus, the hypothalamus and in the frontal cortex.
Interferon-γ, a cytokine that induces activity in enzymes involved in
tryptophan metabolism, was also increased in the frontal cortex at that
time point. Noradrenaline may be important for effortful attention and
for focusing on salient cues. Whether IFN- γ induced changes in neu-
rotransmitter balance or noradrenaline depletion may influence the
way in which pigs respond to social cues will be studied in group-
housed pigs.
Acknowledgements
We thank Mette Værum Olesen for skilfully carrying out the sur-
geries. The staff at the Department of Production Animal Clinical
Sciences at NMBU's Faculty of Veterinary Medicine is acknowledged for
caretaking of the animals. We thank Grethe Marie Johansen and Hege
Lund at the Department of Food Safety and Infection Biology for the
isolation, freezing, staining and analysis of flow cytometric samples. We
are grateful to two anonymous reviewers for valuable comments. This
study was part of the ANIHWA ERA-net project FareWellDock, funded
by the Norwegian Research Council (NRC project number 236518) and
the Finnish Ministry of Agriculture and Forestry (project numbers
1564/311/2013 and 1697/312/2014). Networking activities were
partly funded by COST ActionCA15134 - Synergy for preventing da-
maging behaviour in group housed pigs and chickens
(GroupHouseNet), supported by COST (European Cooperation in
Science and Technology: www.cost.eu). The authors declare no com-
peting interests.
Appendix A. Supplementary data
Supplementary data to this article can be found online at https://
doi.org/10.1016/j.physbeh.2018.07.013.
References
[1] P.K. Almond, G. Bilkei, Effects of oral vaccination against Lawsonia intracellullaris
on growing-finishing pig's performance in a pig production unit with endemic
porcine proliferative enteropathy (PPE), Deut. Tierärtzl. Woch. 113 (2006)
232–235.
[2] M. Barnikol, Observations of tail biting (cannibalism) amongst fattening hogs and
breeding pigs in connection with protein and mineral nourishment, Tierärtzl.
Umschau. 33 (1978) 540–546.
[3] R.B. D'Eath, G. Arnott, S.P. Turner, T. Jensen, H.P. Lahrmann, M.E. Busch,
J.K. Niemi, A.B. Lawrence, P. Sandoe, Injurious tail biting in pigs: how can it be
controlled in existing systems without tail docking? Animal 8 (2014) 1479–1497.
[4] C. Moinard, M. Mendl, C.J. Nicol, L.E. Green, A case control study of on-farm risk
factors for tail biting in pigs, Appl. Anim. Behav. Sci. 81 (2003) 333–355.
[5] J.K. Niemi, A. Sinisalo, A.H.M. Valros, The Timing and Treatment of Tail Biting in
Fattening Pigs, Nordic Association of Agricultural Scientists. SLU, Uppsala, Sweden,
2011 (p. 6).
[6] N.R. Taylor, R.M.A. Parker, M. Mendl, S.A. Edwards, D.C.J. Main, Prevalence of risk
factors for tail biting on commercial farms and intervention strategies, Vet. J. 194
(2012) 77–83.
J. Nordgreen et al. Physiology & Behavior 195 (2018) 98–111
109
[7] R. Dantzer, J.C. O'Connor, G.G. Freund, R.W. Johnson, K.W. Kelley, From in-
flammation to sickness and depression: when the immune system subjugates the
brain, Nat. Rev. Neurosci. 9 (2008) 46–57.
[8] B.L. Hart, Biological basis of the behavior of sick animals, Neurosci. Biobehav. Rev.
12 (1988) 123–137.
[9] L. Capuron, A. Ravaud, R. Dantzer, Early depressive symptoms in cancer patients
receiving interleukin 2 and/or interferon alfa-2b therapy, J. Clin. Oncol. 18 (2000)
2143–2151.
[10] A. Constant, L. Castera, R. Dantzer, P. Couzigou, V. de Ledinghen, J. Demotes-
Mainard, C. Henry, Mood alterations during interferon-alfa therapy in patients with
chronic hepatitis C: evidence for an overlap between manic/hypomanic and de-
pressive symptoms, J. Clin. Psychiat. 66 (2005) 1050–1057.
[11] K.D. Denicoff, D.R. Rubinow, M.Z. Papa, C. Simpson, C.A. Seipp, M.T. Lotze,
A.E. Chang, D. Rosenstein, S.A. Rosenberg, The neuropsychiatric effects of treat-
ment with interleukin-2 and lymphokine-activated killer-cells, Ann. Intern. Med.
107 (1987) 293–300.
[12] P.F. Renault, J.H. Hoofnagle, Y. Park, K.D. Mullen, M. Peters, B. Jones, V. Rustgi,
A. Jones, Psychiatric complications of long-term interferon alfa therapy, Arch.
Intern. Med. 147 (1987) 1577–1580.
[13] E.F. Coccaro, R. Lee, J.R. Fanning, D. Fuchs, M. Goiny, S. Erhardt, K. Christensen,
L. Brundin, M. Coussons-Read, Tryptophan, kynurenine, and kynurenine metabo-
lites: relationship to lifetime aggression and inflammatory markers in human sub-
jects, Psychoneuroendocrinology 71 (2016) 189–196.
[14] K.M. Bouwman, D.M. Hawley, Sickness behaviour acting as an evolutionary trap?
Male house finches preferentially feed near diseased conspecifics, Biol. Lett. 6
(2010) 462–465.
[15] L. Capuron, J.F. Gumnick, D.L. Musselman, D.H. Lawson, A. Reemsnyder,
C.B. Nemeroff, A.H. Miller, Neurobehavioral effects of interferon-alpha in cancer
patients: phenomenology and paroxetine responsiveness of symptom dimensions,
Neuropsychopharmacology 26 (2002) 643–652.
[16] R.P.A. Gaykema, L.E. Goehler, Ascending caudal medullary catecholamine path-
ways drive sickness-induced deficits in exploratory behavior: brain substrates for
fatigue? Brain Behav. Immun. 25 (2011) 443–460.
[17] A.K. Walker, D.P. Budac, S. Bisulco, A.W. Lee, R.A. Smith, B. Beenders, K.W. Kelley,
R. Dantzer, NMDA receptor blockade by ketamine abrogates lipopolysaccharide-
induced depressive-like behavior in C57BL/6J mice, Neuropsychopharmacology 38
(2013) 1609–1616.
[18] A. Valros, P. Palander, M. Heinonen, C. Munsterhjelm, E. Brunberg, L. Keeling,
P. Piepponen, Evidence for a link between tail biting and central monoamine me-
tabolism in pigs (Sus scrofa domestica), Physiol. Behav. 143 (2015) 151–157.
[19] W. Ursinus, C.G. Van Reenen, I. Reimert, J.E. Bolhuis, Tail biting in pigs: blood
serotonin and fearfulness as pieces of the puzzle? PLoS One 9 (2014).
[20] A. Poltorak, X.L. He, I. Smirnova, M.Y. Liu, C. Van Huffel, X. Du, D. Birdwell,
E. Alejos, M. Silva, C. Galanos, M. Freudenberg, P. Ricciardi-Castagnoli, B. Layton,
B. Beutler, Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations
in Tlr4 gene, Science 282 (1998) 2085–2088.
[21] S.T. Qureshi, L. Lariviere, G. Leveque, S. Clermont, K.J. Moore, P. Gros, D. Malo,
Endotoxin-tolerant mice have mutations in toll-like receptor 4 (Tlr4), J. Exp. Med.
189 (1999) 615–625.
[22] J. Schletter, H. Heine, A.J. Ulmer, E.T. Rietschel, Molecular mechanisms of en-
dotoxin activity, Arch. Microbiol. 164 (1995) 383–389.
[23] D.M. Steel, A.S. Whitehead, The major acute-phase reactants- C-reactive protein,
serum amyloid-P component and serum amyloid-a protein, Immunol. Today 15
(1994) 81–88.
[24] R.J. Ulevitch, P.S. Tobias, Receptor-dependent mechanisms of cell stimulation by
bacterial endotoxin, Annu. Rev. Immunol. 13 (1995) 437–457.
[25] S.D. Wright, Toll, a new piece in the puzzle of innate immunity, J. Exp. Med. 189
(1999) 605–609.
[26] S.D. Wright, R.A. Ramos, P.S. Tobias, R.J. Ulevitch, J.C. Mathison, CD14, a receptor
for complexes of lipopolysaccharide (LPS) and LPS binding-protein, Science 249
(1990) 1431–1433.
[27] S.L. Moya, L.A. Boyle, P.B. Lynch, S. Arkins, Surgical castration of pigs affects the
behavioral response to a low-dose lipopolysaccharide (LPS) challenge after
weaning, Appl. Anim. Behav. Sci. 112 (2008) 40–57.
[28] D.C. Lay, H.G. Kattesh, J.E. Cunnick, M.J. Daniels, G. Kranendonk, K.A. McMunn,
M.J. Toscano, M.P. Roberts, Effect of prenatal stress on subsequent response to
mixing stress and a lipopolysaccharide challenge in pigs, J. Anim. Sci. 89 (2011)
1787–1794.
[29] H. Wyns, S. Croubels, M. Vandekerckhove, K. Demeyere, P. De Backer,
B.M. Goddeeris, E. Meyer, Multiplex analysis of pro-inflammatory cytokines in
serum of Actinobacillus pleuropneumoniae-infected pigs, Res. Vet. Sci. 102 (2015)
45–48.
[30] J.A. Carroll, D.B. Carter, S.W. Korte, R.S. Prather, Evaluation of the acute phase
response in cloned pigs following a lipopolysaccharide challenge, Domest. Anim.
Endocrinol. 29 (2005) 564–572.
[31] J.A. Carroll, K.J. Touchette, R.L. Matteri, C.J. Dyer, G.L. Allee, Effect of spray-dried
plasma and lipopolysaccharide exposure on weaned rigs: II. Effects on the hy-
pothalamic-pituitary-adrenal axis of weaned pigs, J. Anim. Sci. 80 (2002) 502–509.
[32] R.F. Parrott, S.V. Vellucci, J.A. Goode, D.M. Lloyd, M.L. Forsling, Interrelated
adrenocortical and neurohypophysial responses associated with fever in endotoxin-
treated pigs, Am. J. Physiol.-Regulatory Integ. Comp. Physiol. 273 (1997)
R1046–R1052.
[33] P.N. Williams, C.T. Collier, J.A. Carroll, T.H. Welsh, J.C. Laurenz, Temporal pattern
and effect of sex on lipopolysaccharide-induced stress hormone and cytokine re-
sponse in pigs, Domest. Anim. Endocrinol. 37 (2009) 139–147.
[34] L.T. van Eijk, M.J. Dorresteijn, P. Smits, J.G. van der Hoeven, M.G. Netea,
P. Pickkers, Gender differences in the innate immune response and vascular re-
activity following the administration of endotoxin to human volunteers, Crit. Care
Med. 35 (2007) 1464–1469.
[35] A. Prohl, C.H. Ostermann, C.D. Rummell, J. Rothe, P. Reinholdl, Circulating and
broncho-alveolar interleukin-6 in relation to body temperature in an experimental
model of bovine Chlamydia psittaci infection, PLoS One 12 (2017) 14.
[36] P. Bard, V.B. Mountcastle, Suppression and facilitation of angry behavior by certain
forebrain mechanisms, Science 107 (1948) 457.
[37] A.R. Damasio, On some functions of the human prefrontal cortex, in: J. Grafman,
K.J. Holyoak, F. Boller (Eds.), Structure and Functions of the Human Prefrontal
Cortex, New York Acad Sciences, New York, 1995, pp. 241–251.
[38] A.F.T. Arnsten, Stress signalling pathways that impair prefrontal cortex structure
and function, Nat. Rev. Neurosci. 10 (2009) 410–422.
[39] J.A. Milstein, O. Lehmann, D.E.H. Theobald, J.W. Dalley, T.W. Robbins, Selective
depletion of cortical noradrenaline by anti-dopamine beta-hydroxylase-saporin
impairs attentional function and enhances the effects of guanfacine in the rat,
Psychopharmacologia 190 (2007) 51–63.
[40] T.A. Niendam, A.R. Laird, K.L. Ray, Y.M. Dean, D.C. Glahn, C.S. Carter, Meta-
analytic evidence for a superordinate cognitive control network subserving diverse
executive functions, Cogn. Affect. Behav. Neurosci. 12 (2012) 241–268.
[41] D.A. Drachman, J. Arbit, Memory and hippocampal complex. 2. Is memory a
multiple process, Arch. Neurol. 15 (1966) 52.
[42] J.L. McClelland, B.L. McNaughton, R.C. Oreilly, Why there are complementary
learning-systems in the hippocampus and neocortex-insights from the successes and
failures of connectionist models of lerning and memory, Psychol. Rev. 102 (1995)
419–457.
[43] B.L. McNaughton, F.P. Battaglia, O. Jensen, E.I. Moser, M.B. Moser, Path integration
and the neural basis of the 'cognitive map', Nat. Rev. Neurosci. 7 (2006) 663–678.
[44] B.K. Anand, J.R. Brobeck, Hypothalamic control of food intake in rats and cats, Yale
J. Biol. Med. 24 (1951) 123–140.
[45] T. Hori, T. Nakashima, H. Koga, T. Kiyohara, T. Inoue, Convergence of thermal,
osmotic and cardiovascular signals on preoptic and anterior hypothalamic neurons
in the rat, Brain Res. Bull. 20 (1988) 879–885.
[46] C.M. Hueston, T. Deak, The inflamed axis: the interaction between stress, hor-
mones, and the expression of inflammatory-related genes within key structures
comprising the hypothalamic-pituitary-adrenal axis, Physiol. Behav. 124 (2014)
77–91.
[47] R.E. Hulse, P.E. Kunkler, J.P. Fedynyshyn, R.P. Kraig, Optimization of multiplexed
bead-based cytokine immunassays for rat serum and brain tissue, J. Neurosci.
Methods 136 (2004) 87–98.
[48] M. Kjelgaard-Hansen, A.L. Jensen, A.T. Kristensen, Evaluation of a commercially
available human C-reactive protein (CRP) turbidometric immunoassay for de-
termination of canine serum CRP concentration, Vet. Clin. Pathol. 32 (2003) 81–87.
[49] R.C. Antweiler, Evaluation of statistical treatments of left-censored environmental
data using coincident uncensored data sets. II. Group comparisons, Environ. Sci.
Technol. 49 (2015) 13439–13446.
[50] E.J. Breen, W. Tan, A. Khan, The statistical value of raw fluorescence signal in
luminex xMAP based multiplex immunoassays, Sci. Rep. 6 (2016) 13.
[51] K.H. Mair, S.E. Essler, M. Patzl, A.K. Storset, A. Saalmuller, W. Gerner, NKp46 ex-
pression discriminates porcine NK cells with different functional properties, Eur. J.
Immunol. 42 (2012) 1261–1271.
[52] D.M. Webel, B.N. Finck, D.H. Baker, R.W. Johnson, Time course of increased plasma
cytokines, cortisol, and urea nitrogen in pigs following intraperitoneal injection of
lipopolysaccharide, J. Anim. Sci. 75 (1997) 1514–1520.
[53] H. Engler, S. Benson, A. Wegner, I. Spreitzer, M. Schedlowski, S. Elsenbruch, Men
and women differ in inflammatory and neuroendocrine responses to endotoxin but
not in the severity of sickness symptoms, Brain Behav. Immun. 52 (2016) 18–26.
[54] J. Lasselin, S. Elsenbruch, M. Lekander, J. Axelsson, B. Karshikoff, J.S. Grigoleit,
H. Engler, M. Schedlowski, S. Benson, Mood disturbance during experimental en-
dotoxemia: predictors of state anxiety as a psychological component of sickness
behavior, Brain Behav. Immun. 57 (2016) 30–37.
[55] A. Marraffa, M. Lekander, P. Solsjo, M.J. Olsson, J. Lasselin, J. Axelsson, Yawning, a
thermoregulatory mechanism during fever? A study of yawning frequency and its
predictors during experimentally induced sickness, Physiol. Behav. 182 (2017)
27–33.
[56] C. Munsterhjelm, J. Nordgreen, F. Aae, M. Heinonen, K. Olstad, T. Aasmundstad,
A.M. Janczak, A. Valros, To be blamed or pitied? The effect of illness on social
behavior, cytokine levels and feed intake in undocked boars, Physiol. Behav. 179
(2017) 298–307.
[57] J.W. Frank, J.A. Carroll, G.L. Allee, M.E. Zannelli, The effects of thermal environ-
ment and spray-dried plasma on the acute-phase response of pigs challenged with
lipopolysaccharide, J. Anim. Sci. 81 (2003) 1166–1176.
[58] K.J. Touchette, J.A. Carroll, G.L. Allee, R.L. Matteri, C.J. Dyer, L.A. Beausang,
M.E. Zannelli, Effect of spray-dried plasma and lipopolysaccharide exposure on
weaned pigs: I. Effects on the immune axis of weaned pigs, J. Anim. Sci. 80 (2002)
494–501.
[59] J. de Groot, G. Kranendonk, M. Fillerup, H. Hopster, W. Boersma, D. Hodgson,
K. van Reenen, M. Taverne, Response to LPS in female offspring from sows treated
with cortisol during pregnancy, Physiol. Behav. 90 (2007) 612–618.
[60] J.N. Marchant-Forde, D.L. Matthews, R. Poletto, R.R. McCain, D.D. Mann,
R.T. Degraw, J.M. Hampsch, S. Peters, G.T. Knipp, C.B. Kissinger, Plasma cortisol
and noradrenalin concentrations in pigs: automated sampling of freely moving pigs
housed in the PigTurn® versus manually sampled and restrained pigs, Anim. Welf.
21 (2012) 197–205.
[61] L. Fairbairn, R. Kapetanovic, D. Beraldi, D.P. Sester, C.K. Tuggle, A.L. Archibald,
D.A. Hume, Comparative analysis of monocyte subsets in the pig, J. Immunol. 190
J. Nordgreen et al. Physiology & Behavior 195 (2018) 98–111
110
(2013) 6389–6396.
[62] T. Tak, R. van Groenendael, P. Pickkers, L. Keonderman, Monocyte subsets are
differentially lost from the circulation during acute inflammation induced by
human experimental endotoxemia, J. Innate Immun. 9 (2017) 464–474.
[63] H. Lund, P. Boysen, C.P. Åkesson, A.M. Lewandowska-Sabat, A.K. Storset, Transient
migration of large numbers of cD14++ cD16+ monocytes to the draining lymph
node after onset of inflammation, Front. Immunol. 7 (2016), https://doi.org/10.
3389/fimmu.2016.00322.
[64] A.A. Patel, Y. Zhang, J.N. Fullerton, L. Boelen, A. Rongvaux, A.A. Maini, V. Bigley,
R.A. Flavell, D.W. Gilroy, B. Asquith, D. Macallan, S. Yona, The fate and lifespan of
human monocyte subsets in steady state and systemic inflammation, J. Exp. Med.
214 (2017) 1913–1923.
[65] B. Thaler, P.J. Hohensinner, K.A. Krychtiuk, P. Matzneller, L. Koller, M. Brekalo,
G. Maurer, K. Huber, M. Zeitlinger, B. Jilma, J. Wojta, W.S. Speidl, Differential in
vivo activation of monocyte subsets during lowgrade inflammation through ex-
perimental endotoxemia in humans, Sci. Rep. 6 (2016) 30162.
[66] M. Prinz, J. Priller, S.S. Sisodia, R.M. Ransohoff, Heterogeneity of CNS myeloid cells
and their roles in neurodegeneration, Nat. Neurosci. 14 (2011) 1227–1235.
[67] Y. Guo, N.K. Patil, L. Luan, J.K. Bohannon, E.R. Sherwood, The biology of natural
killer cells during sepsis, Immunology (2017), https://doi.org/10.1111/imm.
12854.
[68] L.Y. Qin, X.F. Wu, M.L. Block, Y.X. Liu, G.R. Breese, J.S. Hong, D.J. Knapp,
F.T. Crews, Systemic LPS causes chronic neuroinflammation and progressive neu-
rodegeneration, Glia 55 (2007) 453–462.
[69] D. Damotte, C. Goulvestre, J. Charreire, C. Carnaud, LPS and Freund's adjuvant
initiate different inflammatory circuits in experimental autoimmune thyroiditis,
Eur. Cyt. Network 14 (2003) 52–59.
[70] Y. Liu, H. Yin, M. Zhao, Q. Lu, TLR2 and TLR4 in autoimmune diseases: a com-
prehensive review, Clin. Rev. Allergy Immunol. 47 (2014) 136–147.
[71] M. Robinet, S. Maillard, M.A. Cron, S. Berrih-Aknin, R. Le Panse, Review on toll-like
receptor activation in myasthenia gravis: application to the development of new
experimental models, Clin. Rev. Allergy Immunol. 52 (2017) 133–147.
[72] R.W. Johnson, E. von Borell, Lipopolysaccharide-induced sickness behavior in pigs
is inhibited by pretreatment with indomethacin, J. Anim. Sci. 72 (1994) 309–314.
[73] E.J. Warren, B.N. Finck, S. Arkins, K.W. Kelley, R.W. Scamurra, M.P. Murtaugh,
R.W. Johnson, Coincidental changes in behavior and plasma cortisol in unrest-
rained pigs after intracerebroventricular injection of tumor necrosis factor-alpha,
Endocrinology 138 (1997) 2365–2371.
[74] S. Fujigaki, K. Saito, K. Sekikawa, S. Tone, O. Takikawa, H. Fujii, H. Wada,
A. Noma, M. Seishima, Lipopolysaccharide induction of indoleamine 2,3-dioxy-
genase is mediated dominantly by an IFN-gamma-independent mechanism, Eur. J.
Immunol. 31 (2001) 2313–2318.
[75] J.C. O'Connor, M.A. Lawson, C. Andre, M. Moreau, J. Lestage, N. Castanon,
K.W. Kelley, R. Dantzer, Lipopolysaccharide-induced depressive-like behavior is
mediated by indoleamine 2,3-dioxygenase activation in mice, Mol. Psychiatry 14
(2009) 511–522.
[76] O. Takikawa, Y. Tagawa, Y. Iwakura, R. Yoshida, R.J.W. Truscott, Interferon-
gamma-dependent/independent expression of indoleamine 2,3-dioxygenase.
Studies with interferon-gamma-knockout mice, in: G. Huether, W. Kochen,
T.J. Simat, H. Steinhart (Eds.), Tryptophan, Serotonin and Melatonin: Basic Aspects
and Applications, vol. 467, Kluwer Academic/Plenum Publishing, New York, 1999,
pp. 553–557.
[77] T. Tesch, E. Bannert, J. Kluess, J. Frahm, L. Huether, S. Kersten, G. Breves,
L. Renner, S. Kahlert, H.J. Roethkoetter, S. Daenicke, Relationships between body
temperatures and inflammation indicators under physiological and pathophysio-
logical conditions in pigs exposed to systemic lipopolysaccharide and dietary
deoxynivalenol, J. Anim. Physiol. Anim. Nutr. 102 (2018) 241–251.
[78] H. Besedovsky, A. Delrey, E. Sorkin, M. Daprada, R. Burri, C. Honegger, The im-
mune-response evokes changes in brain noradrenergic neurons, Science 221 (1983)
564–566.
[79] M.I. Masana, M.P. Heyes, I.N. Mefford, Indomethacin prevents increased cathe-
cholamine turnover in rat brain following systemic endotoxin challenge, Prog.
Neuro-Psychopharm. Biol. Psychiat. 14 (1990) 609–621.
[80] A.C.E. Linthorst, C. Flachskamm, F. Holsboer, J. Reul, Activation of serotonergic
and noradrenergic neurotransmission in the rat hippocampus after peripheral ad-
ministration of bacterial endotoxin: involvement of the cyclo-oxygenase pathway,
Neuroscience 72 (1996) 989–997.
[81] M. Sekio, K. Seki, Lipopolysaccharide-induced depressive-like behavior is asso-
ciated with alpha(1)-adrenoceptor dependent downregulation of the membrane
GluR1 subunit in the mouse medial prefrontal cortex and ventral tegmental area,
Int. J. Neuropsychopharmacol. 18 (2015) 12.
[82] N. Kurosawa, K. Shimizu, K. Seki, The development of depression-like behavior is
consolidated by IL-6-induced activation of locus coeruleus neurons and IL-1 beta-
induced elevated leptin levels in mice, Psychopharmacologia 233 (2016)
1725–1737.
[83] C. Feleder, V. Perlik, C.M. Blatteis, Preoptic norepinephrine mediates the febrile
response of Guinea pigs to lipopolysaccharide, Am. J. Physiol. Reg. Integr. Comp.
Physiol. 293 (2007) R1135–R1143.
[84] J. Roth, C.M. Blatteis, Mechanisms of fever production and lysis: lessons from ex-
perimental LPS fever, Compr. Physiol. 4 (2014) 1563–1604.
[85] A. Frazer, D.A. Morilak, What should animal models of depression model? Neurosci.
Biobehav. Rev. 29 (2005) 515–523.
[86] D.A. Morilak, A. Frazer, Antidepressants and brain monoaminergic systems: a di-
mensional approach to understanding their behavioral effects in depression and
anxiety disorders, Int. J. Neuropsychopharm. 7 (2004) 193–218.
[87] M.M. Katz, J.L. Tekell, C.L. Bowden, S. Brannan, J.P. Houston, N. Berman,
A. Frazer, Onset and early behavioral effects of pharmacologically different anti-
depressants and placebo in depression, Neuropsychopharmacology 29 (2004)
566–579.
[88] G. Aston-Jones, J. Rajkowski, J. Cohen, Role of locus coeruleus in attention and
behavioral flexibility, Biol. Psychiatry 46 (1999) 1309–1320.
J. Nordgreen et al. Physiology & Behavior 195 (2018) 98–111
111
